Bioequivalence and Bioavailability Forum • Tramadol BE study

Tramadol BE study [Design Issues]

posted by nermina – Bosnia and Herzegovina, 2010-01-15 17:15 (6004 d 02:43 ago) – Posting: # 4610
Views: 8,191

Thanks for a prompt answer. I saw on web of UK regulatory agency (www.mhra.gov.uk) in Public assessment report, that they've required a determination of M1 metabolite too. That confused me.

Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Helmut]

Complete thread:

Tramadol BE study nermina 2010-01-15 15:27
- Tramadol BE study Helmut 2010-01-15 16:08
  - Tramadol BE studynermina 2010-01-15 16:15
    - Tramadol BE study Helmut 2010-01-15 16:40
      - Tramadol BE study mvgchakravarthi 2010-01-18 15:19
        
        Tramadol BE study Helmut 2010-01-18 15:44
        
        Tramadol BE study raghu 2010-01-20 17:53
        
        MA (EU) vs. ANDA (USA) Helmut 2010-01-20 18:18
      - Tramadol BE study ratna 2010-01-21 06:36
- Tramadol BE study Otto 2010-01-25 13:26
  - Therapeutic Equivalence vs. Pharmaceutical Quality Helmut 2010-02-07 17:01
    - Therapeutic Equivalence vs. Pharmaceutical Quality kumarnaidu 2014-03-15 11:36